Role of Phosphorylation in Agonist-promoted β2-Adrenergic Receptor Sequestration
Open accessThe DOI matches its Crossref record.
Abstract
The beta 2-adrenergic receptor (beta 2AR) belongs to the large family of G protein-coupled receptors. Mutation of tyrosine residue 326 to an alanine resulted in a beta 2AR mutant (beta 2AR-Y326A) that was defective in its ability to sequester and was less well coupled to adenylyl cyclase than the wild-type beta 2AR. However, this mutant receptor not only desensitized in response to agonist stimulation but down-regulated normally. In an attempt to understand the basis for the properties of this mutant, we have examined the ability of this regulation-defective mutant to undergo agonist-mediated phosphorylation. When expressed in 293 cells, the maximal response for phosphorylation of the beta 2AR-Y326A mutant was impaired by 75%. Further characterization of this phosphorylation, using either forskolin stimulation or phosphorylation site-deficient beta 2AR-Y326A mutants, demonstrated that the beta 2AR-Y326A mutant can be phosphorylated by cAMP-dependent protein kinase (PKA) but does not serve as a substrate for the beta-adrenergic receptor kinase 1 (beta ARK1). However, overexpression of beta ARK1 led to the agonist-dependent phosphorylation of the beta 2AR-Y326A mutant and rescue of its sequestration. beta ARK1-mediated rescue of beta 2AR-Y326A sequestration could be prevented by mutating putative beta ARK phosphorylation sites, but not PKA phosphorylation sites. In addition, both sequestration and phosphorylation of the wild-type beta 2AR could be attenuated by overexpressing a dominant-negative mutant of beta ARK1 (C20 beta ARK1-K220M). These findings implicate a role for beta ARK1-mediated phosphorylation in facilitating wild-type beta 2AR sequestration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
Self-citationβ-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Self-citationβ-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,384
G PROTEIN–COUPLED RECEPTOR KINASES
Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,361
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
Krupnick, J. G., & Benovic, J. L. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.289 · Cited by 1,103
Lefkowitz, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18677 · Cited by 1,044
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972
Self-citationOakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G., & Barak, L. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910348199 · Cited by 882
Self-citationCLATHRIN-COATED VESICLE FORMATION AND PROTEIN SORTING: An Integrated Process
Schmid, S. L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.511 · Cited by 799
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
Déry, O., Corvera, C. U., Steinhoff, M., & Bunnett, N. W. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.6.c1429 · Cited by 779
Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32248 · Cited by 567
Self-citationClaing, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00023-5 · Cited by 519
Regulatory mechanisms that modulate signalling by G-protein-coupled receptors
BÖHM, S. K., GRADY, E. F., & BUNNETT, N. W. (1997) · Biochemical Journal · doi:10.1042/bj3220001 · Cited by 505
Zhang, J., Ferguson, S. S. G., Barak, L. S., Bodduluri, S. R., Laporte, S. A., Law, P.-Y., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7157 · Cited by 505
Self-citationDynamin and β-Arrestin Reveal Distinct Mechanisms for G Protein-coupled Receptor Internalization
Zhang, J., Ferguson, S. S. G., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18302 · Cited by 459
Self-citationOakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101450200 · Cited by 455
A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation
Barak, L. S., Ferguson, S. S. G., Zhang, J., & Caron, M. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27497 · Cited by 428
Self-citationLaporte, S. A., Oakley, R. H., Holt, J. A., Barak, L. S., & Caron, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002581200 · Cited by 401
Self-citationEndocytosis and recycling of G protein-coupled receptors
Koenig, J. A., & Edwardson, J. M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01091-2 · Cited by 357
G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins
Ferguson, S. S. G., Barak, L. S., Zhang, J., & Caron, M. G. (1996) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-74-10-1095 · Cited by 330
Self-citationWhalen, E. J., Foster, M. W., Matsumoto, A., Ozawa, K., Violin, J. D., Que, L. G., Nelson, C. D., Benhar, M., Keys, J. R., Rockman, H. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.02.046 · Cited by 311
Self-citationAngiotensin II Signal Transduction in Vascular Smooth Muscle: Role of Tyrosine Kinases
Berk, B. C., & Corson, M. A. (1997) · Circulation Research · doi:10.1161/01.res.80.5.607 · Cited by 305
Krupnick, J. G., Goodman, O. B., Keen, J. H., & Benovic, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.15011 · Cited by 303
G-protein-coupled receptors: turn-ons and turn-offs
Carman, C. V., & Benovic, J. L. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80058-5 · Cited by 294
Hicke, L., Zanolari, B., & Riezman, H. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.2.349 · Cited by 269
Trafficking of the HIV Coreceptor CXCR4
Orsini, M. J., Parent, J.-L., Mundell, S. J., & Benovic, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31076 · Cited by 264
Angel, T. E., Chance, M. R., & Palczewski, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903545106 · Cited by 235
“53 to Ala mutation exhibited a reduction in phosphorylation and receptor internalization and reduced G protein coupling (32, 33).”
BackgroundLorton, D., & Bellinger, D. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16035635 · Cited by 221
“Signaling of β2-ARs through β-arrestin 2 induces sustained ERK1/2 rather than the traditional cAMP-PKA signaling [29,31,38,48,92].”
BackgroundAkinaga, J., Lima, V., Kiguti, L. R. D. A., Hebeler-Barbosa, F., Alcántara-Hernández, R., García-Sáinz, J. A., & Pupo, A. S. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.082313 · Cited by 58
Metadata
- Authors
- Ferguson, S. S. G., Ménard, L., Barak, L. S., Koch, W. J., Colapietro, A.-M., & Caron, M. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-10
- Volume
- 270
- Issue
- 42
- Pages
- 24782-24789
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2059247616
- Cited by
- 216
- References
- 0
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.